Company Filing History:
Years Active: 2022
Title: Naomi Tidten-Luksch: Innovator in Medicinal Chemistry
Introduction
Naomi Tidten-Luksch is a prominent inventor based in Allschwil, Switzerland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific enzymes related to cancer treatment. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Naomi Tidten-Luksch holds a patent for "Inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase." This invention relates to compounds of Formula (I) that inhibit the enzymes indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO). The patent outlines the synthesis of these compounds and their potential use as medicaments, particularly in the treatment of cancer. She has 1 patent to her name, reflecting her innovative contributions to the field.
Career Highlights
Naomi is currently employed at Idorsia Pharmaceuticals Ltd., a company known for its commitment to developing innovative therapies. Her role at Idorsia allows her to collaborate with other talented professionals in the pharmaceutical industry, further enhancing her impact on medicinal research.
Collaborations
Throughout her career, Naomi has worked alongside notable colleagues such as Christoph Boss and Daniel Bur. These collaborations have fostered a dynamic environment for innovation and have contributed to the advancement of their shared goals in medicinal chemistry.
Conclusion
Naomi Tidten-Luksch is a remarkable inventor whose work in developing inhibitors for specific enzymes has the potential to revolutionize cancer treatment. Her contributions to Idorsia Pharmaceuticals Ltd. and her innovative patent highlight her significant role in the field of medicinal chemistry.